![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, January 08, 2015 10:36:54 AM
Why is it that we have not heard of any development for months on the status of HemaXellerate I and DCellVax progress? Why, if there has been any progress going forward, why wouldn't they want to brag about it? Instead, we are 2 years removed from IND of HemaXellerate with nothing to show but a 2/3rds approval for clinical trials and no update for months whether there is any hope that it will ever take place, since the safe data was lacking and we have no update as to whether any further testing is being performed. DCellVax is over its projected submission for approval, so, in fact, why should we think this N... will be any different.
On the other hand, companies are breaking ground. Just came across JUNO which IPOed at 24 and is now over 50 within days on cell based cancer treatments. The more time passes without positive, concrete news on data and results, the less chance RGBP will ever make it.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM